SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-072466
Filing Date
2020-06-11
Accepted
2020-06-11 17:01:04
Documents
5
Effectiveness Date
2020-06-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2022344d1_s8.htm S-8 77764
2 EXHIBIT 5.1 tm2022344d1_ex5-1.htm EX-5.1 10025
3 EXHIBIT 23.2 tm2022344d1_ex23-2.htm EX-23.2 5286
4 GRAPHIC image_001.jpg GRAPHIC 1763
5 GRAPHIC image_002.jpg GRAPHIC 2301
  Complete submission text file 0001104659-20-072466.txt   100190
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239101 | Film No.: 20957821
SIC: 2836 Biological Products, (No Diagnostic Substances)